Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine receptor D2 (D2R) is a G protein-coupled receptor (GPCR) encoded by the DRD2 gene. It plays a crucial role in regulating dopamine neurotransmission, influencing motor control, motivation, reward processing, and mood. It exists in two main isoforms, a long (D2L) postsynaptic form and a short (D2S) presynaptic autoreceptor form. D2R is a primary target for antipsychotic drugs and is implicated in several neurological and psychiatric disorders, including Parkinson's disease and addiction. The receptor also forms heteromers with other GPCRs, modulating its pharmacology and functional output.
Antagonism at D2 receptor
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor Type 2 (DRD2).